Cash & equivalents increased 47.4%
Cash & equivalents changed +47.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +47.4% from the comparable as-filed period.
Current liabilities changed +59.6% from the comparable as-filed period.
Net debt changed -24.5% from the comparable as-filed period.
Current assets changed +26.4% from the comparable as-filed period.
Research & development changed +33.0% from the comparable as-filed period.
Debt / assets changed -560 basis points from the comparable as-filed period.
Debt / revenue changed -5804 basis points from the comparable as-filed period.
Stock-based compensation changed +64.5% from the comparable as-filed period.
Cash / debt changed +1200 basis points from the comparable as-filed period.
Debt / equity changed -1861 basis points from the comparable as-filed period.
Receivables / revenue changed +577 basis points from the comparable as-filed period.
Revenue changed -1.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +10 basis points from the comparable as-filed period.
Inventory / revenue changed +113 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross debt changed -11.5% from the comparable as-filed period.
Reported total debt changed -11.5% from the comparable as-filed period.
Total assets changed +1.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
SBC / revenue changed +84 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +8.3% from the comparable as-filed period.
Operating income changed +1.4% from the comparable as-filed period.
Current long-term debt changed +1169.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Trade receivables changed +8.5% from the comparable as-filed period.
Operating cash flow changed +0.8% from the comparable as-filed period.
Shares outstanding changed +2.6% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Current ratio changed -20.8% from the comparable as-filed period.
Inventory changed +3.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
R&D / revenue changed +101 basis points from the comparable as-filed period.
Stockholders' equity changed +1.7% from the comparable as-filed period.
Operating cash-flow margin changed +46 basis points from the comparable as-filed period.
Selling, general & administrative changed -3.0% from the comparable as-filed period.
Working capital changed -3.3% from the comparable as-filed period.
Working capital / assets changed -41 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.